ResearcherNagoya UniversityNo recent work listed
Akihiro Hirakawa
Matched on ORCID iD 0000-0003-2580-7460; OpenAlex author ID A5022561314. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper
Papers 4
- Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 … Co-author DOI 10.18999/nagjms.81.2.233↗
- Comparison of the Survival Outcomes of Pancreatic Cancer and Intraductal Papillary Mucinous Neoplasms. Co-author DOI 10.1097/mpa.0000000000001110↗
- Lymph node ratio as parameter of regional lymph node involvement in pancreatic cancer. Co-author DOI 10.1007/s00423-016-1412-5↗
- Reply to: appropriate statistical descriptions for evaluating the predictive role of epithelial-to-mesenchymal transition in patients with pancreatic cancer. First author DOI 10.1016/j.surg.2014.02.021↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Suguru Yamada · 4 shared papers, 2014–2019 · strength 0.30
- Paper Reply to: appropriate statistical descriptions for evaluating the predictive role of epithelial-to-mesenchymal transiti… DOI 10.1016/j.surg.2014.02.021↗
- Paper Lymph node ratio as parameter of regional lymph node involvement in pancreatic cancer. DOI 10.1007/s00423-016-1412-5↗
- Paper Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pan… DOI 10.18999/nagjms.81.2.233↗
- Yasuhiro Kodera · 3 shared papers, 2016–2019 · strength 0.21
- Paper Lymph node ratio as parameter of regional lymph node involvement in pancreatic cancer. DOI 10.1007/s00423-016-1412-5↗
- Paper Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pan… DOI 10.18999/nagjms.81.2.233↗
- Paper Comparison of the Survival Outcomes of Pancreatic Cancer and Intraductal Papillary Mucinous Neoplasms. DOI 10.1097/mpa.0000000000001110↗
- Tsutomu Fujii · 3 shared papers, 2016–2019 · strength 0.21
- Paper Lymph node ratio as parameter of regional lymph node involvement in pancreatic cancer. DOI 10.1007/s00423-016-1412-5↗
- Paper Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pan… DOI 10.18999/nagjms.81.2.233↗
- Paper Comparison of the Survival Outcomes of Pancreatic Cancer and Intraductal Papillary Mucinous Neoplasms. DOI 10.1097/mpa.0000000000001110↗
- Mitsuro Kanda · 2 shared papers, 2016–2018 · strength 0.14
- Masaya Suenaga · 2 shared papers, 2018–2019 · strength 0.14
- Masamichi Hayashi · 2 shared papers, 2018–2019 · strength 0.14
- Hiroyuki Sugimoto · 1 shared paper, 2016 · strength 0.07
- Takuya Ishikawa · 1 shared paper, 2019 · strength 0.07
- Fuminori Sonohara · 1 shared paper, 2019 · strength 0.07
- Yukio Ando · 1 shared paper, 2019 · strength 0.07
- Masato Nagino · 1 shared paper, 2019 · strength 0.07
- Hidemi Goto · 1 shared paper, 2019 · strength 0.07
- Nao Takano · 1 shared paper, 2019 · strength 0.07
- Shinji Naganawa · 1 shared paper, 2019 · strength 0.07
- Hiroki Kawashima · 1 shared paper, 2019 · strength 0.07
- Junpei Yamaguchi · 1 shared paper, 2019 · strength 0.07
- Eizaburo Ohno · 1 shared paper, 2019 · strength 0.07
- Yukihiro Yokoyama · 1 shared paper, 2019 · strength 0.07
- Osamu Maeda · 1 shared paper, 2019 · strength 0.07
- Yoshiki Hirooka · 1 shared paper, 2019 · strength 0.07
- Norifumi Hattori · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.